Featured Expertise
We understand the nuances of your category from day one.
Can’t see your therapeutic area?
VIEW ALL EXPERTISE3D MOD ANIMATION
This Fusion Animation explores the Genetic Pathways in NASH progression. We detail key risk factors, including the PNPLA3 and TM6SF2 variants. Crucially, the animation focuses on HSD17B13, a promising therapeutic modulation target. We visualize how disease-protective variants suggest that reducing HSD17B13 expression can halt fibrosis. This showcases our expertise in Hepatology, Genetic Disease, and Drug Target MOA concepts.
3D MOD ANIMATION
This Fusion Animation explores the Genetic Pathways in NASH progression. We detail key risk factors, including the PNPLA3 and TM6SF2 variants. Crucially, the animation focuses on HSD17B13, a promising therapeutic modulation target. We visualize how disease-protective variants suggest that reducing HSD17B13 expression can halt fibrosis. This showcases our expertise in Hepatology, Genetic Disease, and Drug Target MOA concepts.
.svg)